Trial Details

UNKNOWN
Basic Information
Clinical ID c939
Identifier NCT05404074
Trial Title Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Cobitolimod 500mg
Participant Information
Sponsor InDex Pharmaceuticals
City Uppsala
Country/Region Sweden
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2021-11-22
Primary Completion Date 2022-10-15
Completion Date 2022-10-30